Giovanni Caforio Insider Profile

11 Followers
Giovanni Caforio, Executive Chair of the Board, Director at Bristol-Myers Squibb, holds 3.21K shares in Stryker (Ticker: SYK), holds 432.27K shares in Bristol-Myers Squibb (Ticker: BMY).
tipranks
Giovanni Caforio

Giovanni Caforio
Bristol-Myers Squibb (BMY)
Executive Chair of the Board, Director

Ranked #51,715 out of 99,335 Corporate Insiders

Profitable Transactions

33%
3 out of 9 Profitable Transactions

Average Return

-1.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$27M
95.36%
4.64%
A breakdown of Giovanni Caforio's holdings

Insider Roles

Bristol-Myers Squibb
(BMY)
Executive Chair of the Board, Director
Stryker
(SYK)
Director
Roles that Giovanni Caforio holds in companies

Most Profitable Insider Trade

Stock:
Bristol-Myers Squibb
(BMY)
Rating:Informative Sell
Date:Feb 08, 2023 - Feb 08, 2024
Return:+31.20%
The most profitable trade made by Giovanni Caforio

Giovanni Caforio's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Bristol-Myers Squibb
Mar 12, 2024
Executive Chair of the Board, Director
Uninformative Buy
6.58M
$25.51M
Stryker
May 13, 2024
Director
Uninformative Buy
$1.24M
List of latest transactions for each holding click on a transaction to see Giovanni Caforio's performance on stock

Giovanni Caforio insider profile FAQ

What is the percentage of profitable transactions made by Giovanni Caforio?
The percentage of profitable transactions made by Giovanni Caforio is 33%.
    What is the average return per transaction made by Giovanni Caforio?
    The average return per transaction made by Giovanni Caforio is -1.00%.
      What stocks does Giovanni Caforio hold?
      Giovanni Caforio holds: BMY, SYK stocks.
        What was Giovanni Caforio’s latest transaction?
        Giovanni Caforio latest transaction was an Uninformative Buy of ―.
          What was Giovanni Caforio's most profitable transaction?
          Giovanni Caforio’s most profitable transaction was an Informative Sell of BMY stock on February 8, 2023. The return on the trade was 31.20%.
            What is Giovanni Caforio's role in Bristol-Myers Squibb?
            Giovanni Caforio's role in Bristol-Myers Squibb is Executive Chair of the Board, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.